Language, law & evidence

Is cannabis a drug?

In modern medical and public-health language, cannabis preparations containing THC are described as psychoactive drugs or substances. But the cannabis plant is also a source of fibre, seed and other materials, and the political question of whether cannabis should be prohibited is separate from what label we use for it.

The semantic question

"Drug" depends on context

Public health

Cannabis is described as psychoactive

The World Health Organization describes cannabis as the most commonly used psychoactive substance under international control and identifies delta-9-tetrahydrocannabinol (THC) as its major psychoactive constituent. In that scientific sense, calling THC-containing cannabis a psychoactive drug is ordinary usage.

WHO 2026 technical brief
Plant & products

Not every cannabis-derived material is the same thing

A cannabis plant can be used to produce psychoactive preparations, medicines, fibre, seed products and cannabinoid extracts. It is therefore useful to distinguish the plant, particular plant parts, THC-containing preparations, isolated cannabinoids and finished products rather than treating every item derived from cannabis as pharmacologically identical.

Home Office cannabis & cannabinoids factsheet
The useful distinction: "Is cannabis a drug?" is partly a language question. "Should adults be criminally punished for possessing, using or growing it?" is a separate legal and political question.

Current UK law

Under UK law, cannabis is a Class B controlled drug

Definition

The plant is controlled, with limited exceptions

Home Office guidance summarises the statutory definition as the cannabis plant or any part of it, subject to limited exceptions including the mature stalk, fibre produced from the mature stalk, and seed.

Home Office factsheet
THC

THC is also controlled

THC and a number of other controlled cannabinoids are Class B drugs in their own right. This is distinct from the legal definition that separately controls cannabis plant material.

Cannabinoid control status
CBD

Pure CBD is not itself controlled under the MDA

The Home Office states that pure isolated CBD is not controlled under the Misuse of Drugs Act 1971. However, a CBD product may still be controlled if it contains controlled cannabinoids unless a relevant exemption or other lawful route applies.

CBD legal guidance
Whether ordinary cannabis leaves are controlled does not simply turn on a forensic laboratory finding THC in those leaves. The legislation separately defines controlled cannabis plant material and controlled cannabinoids.

Health evidence

Low acute toxicity does not mean "harmless"

Low overdose toxicity suggests that cannabis has no meaningful health risks.

Overdose

A fatal overdose from cannabis alone is unlikely

Public-health sources describe fatal overdose caused solely by cannabis as unlikely. But consuming too much can still worsen severe anxiety, confusion, paranoia, vomiting and other reactions, and impairment can contribute to injuries.

CDC cannabis FAQ
Mental health

THC-containing products carry recognised risks

NHS guidance identifies potential risks including psychosis and dependence, with greater concern as THC content increases in a minority of consumers. Illicit products also create uncertainty about strength, ingredients and quality.

NHS medical cannabis
Intoxication

THC can impair judgement and performance

Modern scientific sources describe THC as psychoactive and intoxicating. Cannabis can affect memory, attention, coordination, decision-making and reaction time, particulary in novice consumers. Relgious or ritual use often involves large doses of high-THC content cannabis.

WHO cannabis overview

Pharmacology

Cannabis is not the same thing as purified extracted or chemical THC. THC:CBD ratio is important to consider, as CBD has anti-psychotic properties.

Whole plant or preparation

Cannabis contains many constituents

  • Plant material and extracts contain mixtures of cannabinoids and other compounds.
  • Composition and THC / CBD concentration vary substantially between products.
  • Route of administration and product formulation also change the effects and risks.
  • Findings from a purified compound cannot automatically describe every possible cannabis product.
THC

But THC evidence is directly relevant

  • THC is the major psychoactive constituent of cannabis.
  • Its concentration is an important predictor of intoxicating effects and some risks.
  • Studying THC helps explain effects that arise through cannabinoid receptors.
  • Whole-plant evidence and constituent-specific evidence should be interpreted together, not treated as mutually exclusive.
Also worth separating: synthetic cannabinoids sold as products such as "Spice" are not the same as botanical cannabis. They can have very different potency and risk profiles.

Historical CCGUIDE material

Where the original argument came from

The following pages are retained as historical advocacy and testimony. Their age and context should be kept in mind when comparing them with current medical evidence.

  • DEA Administrative Law Judge Francis L. Young, 1988. A historically important US marijuana-rescheduling opinion that described cannabis as having a wide margin of safety in the therapeutic context. The recommendation did not determine UK law and should not be read as proof that all cannabis use is harmless. CCGUIDE archive
  • Dr Lester Grinspoon testimony, 1997. Historical US congressional testimony arguing for medical access and describing cannabis as relatively safe but not harmless. Read the testimony
  • FCDA Europe report. The source of much of the original "cannabis is not a drug" wording. It is preserved as campaign history, but its claims about addiction, toxicity and health should not be treated as a current clinical consensus. Read the archived report
  • What is not cannabis. An older CCGUIDE page distinguishing botanical cannabis from tobacco mixtures, adulterated products and isolated cannabinoids. Its broader safety claims are historical and should be checked against current evidence. Open the archive page

CCGUIDE campaign perspective

The label does not decide the law

Whether we call cannabis a drug, herb, medicine, intoxicant or controlled substance does not by itself answer the question of what the criminal law ought to do.

CCGUIDE's political conclusion

CCGUIDE continues to argue that adult cannabis possession and cultivation should not attract criminal punishment and that cannabis supply should be addressed through legal reform rather than prohibition alone.

That argument does not require denying that THC is psychoactive, that cannabis can impair people, or that some users develop dependence. Those are evidence questions. Proportionality, regulation and criminalisation are policy questions.

Decriminalisation or legalisation?
Politics

Cannabis politics

Parliamentary, legal and campaign sources on cannabis-law reform.

Open politics
Research

Studies & reports

Verified scientific, government and historical sources collected by CCGUIDE.

Open studies
Law

UK cannabis law

CCGUIDE's legal archive alongside current official guidance.

Open law page

Continue exploring

More CCGUIDE resources

Move from terminology into law, policy, safety and the wider archive.

Campaign

Campaign activities

A chronological archive of UK cannabis campaigning and events.

Open campaign archive
Browse

Alphabetical site index

Find more CCGUIDE pages by subject.

Browse the index
News

World cannabis news

Return to the CCGUIDE news archive.

Open news
Contact

Contact CCGUIDE

Send corrections, surviving links or archive information to the webmaster.

Contact the webmaster